Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 20 | $1,505,687 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 03 Dec 2024 17:24 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 29 Nov 2024 | Sale | 100 | 20 | 2,000 | D |
| 03 Dec 2024 17:24 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 02 Dec 2024 | Sale | 4,088 | 20.2626 | 82,834 | D |
| 03 Dec 2024 17:24 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 03 Dec 2024 | Sale | 11,703 | 20.1475 | 235,786 | D |
| 13 Nov 2024 16:49 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 11 Nov 2024 | Sale | 1,409 | 20.0079 | 28,191 | D |
| 13 Nov 2024 16:49 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 13 Nov 2024 | Sale | 2,700 | 20.0403 | 54,109 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 04 Nov 2024 | Sale | 749 | 18.022 | 13,498 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 05 Nov 2024 | Sale | 5,171 | 18.1795 | 94,006 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 06 Nov 2024 | Sale | 9,554 | 18.7097 | 178,752 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 06 Nov 2024 | Sale | 2,745 | 19.3164 | 53,024 | D |
| 18 Oct 2024 16:31 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 16 Oct 2024 | Sale | 600 | 18 | 10,800 | D |
| 10 Sep 2024 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 09 Sep 2024 | Sale | 2,642 | 15.0879 | 39,862 | D |
| 10 Sep 2024 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 06 Sep 2024 | Sale | 600 | 15.2356 | 9,141 | D |
| 16 Jul 2024 16:43 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 15 Jul 2024 | Sale | 638 | 18 | 11,484 | D |
| 16 Jul 2024 16:43 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 12 Jul 2024 | Sale | 600 | 18 | 10,800 | D |
| 20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 20 May 2024 | Sale | 9,675 | 15.188 | 146,944 | D |
| 20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 May 2024 | Sale | 8,305 | 15.1416 | 125,751 | D |
| 20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 16 May 2024 | Sale | 1,000 | 15 | 15,000 | D |
| 12 Jul 2023 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 11 Jul 2023 | Sale | 14,852 | 18.039 | 267,915 | D |
| 12 Jul 2023 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 10 Jul 2023 | Sale | 3,026 | 18.002 | 54,474 | D |
| 19 Apr 2023 18:06 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 Apr 2023 | Sale | 3,961 | 18.0045 | 71,316 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)